Cargando…
Systemic Lupus Erythematosus, Its Impact on Selected Cardiovascular Risk Factors, and Correlation with Duration of Illness: A Pilot Study
Systemic lupus erythematosus is a rare autoimmune disease. It leads to an increased production of proinflammatory molecules that accelerates atherogenesis and could cause an endothelium dysfunction. The aim of the study was to assess cardiovascular risk factors such as BMI and lipid profile as well...
Autores principales: | Przywara-Chowaniec, Brygida, Blachut, Dominika, Harpula, Jan, Bereś, Marcin, Nowak, Agnieszka, Nowalany-Kozielska, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665909/ https://www.ncbi.nlm.nih.gov/pubmed/33204527 http://dx.doi.org/10.1155/2020/7025329 |
Ejemplares similares
-
The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
por: Blachut, Dominika, et al.
Publicado: (2022) -
Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
por: Nowak, Agnieszka, et al.
Publicado: (2021) -
Systemic lupus erythematosus and glycation process
por: NOWAK, AGNIESZKA, et al.
Publicado: (2020) -
Update of Potential Biomarkers in Risk Prediction and Monitoring of Atherosclerosis in Systemic Lupus Erythematosus to Prevent Cardiovascular Disease
por: Blachut, Dominika, et al.
Publicado: (2023) -
Evaluation of the intima-media complex in patients with systemic lupus erythematosus
por: Przywara-Chowaniec, Brygida, et al.
Publicado: (2014)